abstract |
A method for supplying human iduronic acid 2-sulfatase into a patient's brain to prevent progression of brain damage in a patient with Hunter syndrome. A therapeutic agent containing human iduronic acid 2-sulfatase to be administered into the ventricle of a patient with Hunter syndrome. [Selection figure] None |